Table 2 Group differences of circulating lipid and glucose markers

Study duration

22 weeks (n = 6)

43 weeks (n = 6)

22 weeks (n = 6)

43 weeks (n = 5)

43 weeks (n = 6)

43 weeks (n = 5)

GLU^a (mmol/L)

5.6^A (5.3–5.9)

3.9^A (3.6–4.1)

6.2^A (4.9–6.4)

4.0^A (3.9–4.1)

14.4^B (9.4–15.2)

8.0^C (6.1–8.3)

FRA^b (µmol/L)

257^A (251–269)

226^A (210–237)

251^A (229–266)

242^A (234–252)

410^B (298–444)

340^C (322–387)

K ^a,c_G (min⁻¹⁾

4.5^AB (3.2–5.1)

5.2^A (4.9–6.3)

2.8^AB (2.4–3.2)

3.4^AB (2.4–5.3)

1.2^C (0.4–1.8)

1.4^BC (1.1–1.5)

AUC ^c_insulin (pM min)

4299^A (3173–7746)

6943^A (6356–7399)

5194^A (3676–6236)

11,506^B (10,503–12,714)

1992^A (1669–4937)

4244^A (3368–6747)

TG (mmol/L)

0.43^A (0.35–0.50)

0.34^A (0.29–0.54)

1.09^B (1.03–1.36)

1.26^B (0.75–2.13)

1.42^B (1.26–2.65)

0.92^C (0.9–1.45)

TC^a (mmol/L)

1.77^A (1.46–2.05)

1.85^A (1.53–2.44)

21.70^B (19.93–26.76)

16.95^B (11.64–25.87)

19.53^B (16.59–22.56)

18.87^B (17.64–19.18)

VLDL^b (mmol/L)

0.07^A (0.04–0.10)

0.14^A (0.05–0.69)

13.66^B (9.49–14.62)

12.50^B (7.60–22.32)

12.30^B (10.35–14.19)

10.25^B (9.58–11.58)

LDL^a (mmol/L)

0.72^A (0.51–0.85)

0.67^A (0.64–1.31)

6.72^B (5.12–10.68)

6.22^B (4.05–6.57)

5.42^B (4.16–6.33)

6.21^B (6.01–6.43)

HDL^a (mmol/L)

1.00^A (0.89–1.11)

0.82^A (0.23–1.06)

2.96^B (2.60–3.41)

1.26^B (1.17–1.38)

1.16^B (0.97–1.56)

2.05^B (1.45–2.19)